ZA991301B - Glutamate receptor modulators. - Google Patents
Glutamate receptor modulators.Info
- Publication number
- ZA991301B ZA991301B ZA9901301A ZA991301A ZA991301B ZA 991301 B ZA991301 B ZA 991301B ZA 9901301 A ZA9901301 A ZA 9901301A ZA 991301 A ZA991301 A ZA 991301A ZA 991301 B ZA991301 B ZA 991301B
- Authority
- ZA
- South Africa
- Prior art keywords
- receptor modulators
- glutamate receptor
- glutamate
- modulators
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
- C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
- C07D285/28—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK22698 | 1998-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA991301B true ZA991301B (en) | 1999-09-13 |
Family
ID=8091151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9901301A ZA991301B (en) | 1998-02-18 | 1999-02-18 | Glutamate receptor modulators. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1071426A2 (en) |
| JP (1) | JP2002504481A (en) |
| CN (1) | CN1293665A (en) |
| AU (1) | AU751384B2 (en) |
| CA (1) | CA2320354A1 (en) |
| EE (1) | EE200000468A (en) |
| HU (1) | HUP0101280A3 (en) |
| IL (1) | IL137720A0 (en) |
| IS (1) | IS5581A (en) |
| NO (1) | NO20004121L (en) |
| NZ (1) | NZ506251A (en) |
| PL (1) | PL342843A1 (en) |
| RU (1) | RU2214405C2 (en) |
| SK (1) | SK11892000A3 (en) |
| TR (1) | TR200002427T2 (en) |
| WO (1) | WO1999042456A2 (en) |
| ZA (1) | ZA991301B (en) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7671200B2 (en) | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
| DE10004572A1 (en) | 2000-02-02 | 2001-08-09 | Boehringer Ingelheim Pharma | New positive allosteric AMPA receptor modulators (PAARM), processes for their production and their use as medicines |
| FR2812291B1 (en) * | 2000-07-28 | 2002-12-13 | Adir | NOVEL BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| CN1314351A (en) * | 2001-03-22 | 2001-09-26 | 刘志红 | Process for synthesizing quinazolone and quinazolone compound with anti-cancer function |
| TWI232863B (en) | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
| CN101029051B (en) | 2001-06-14 | 2010-06-09 | 欧加农股份有限公司 | (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the AMPA receptor |
| EP1436270A1 (en) | 2001-10-10 | 2004-07-14 | Neurosearch A/S | Novel benzothiazine derivatives, their preparation and use |
| EA011034B1 (en) * | 2001-11-26 | 2008-12-30 | Кортекс Фармасеутикалс, Инк. | Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| FR2833956B1 (en) * | 2001-12-21 | 2004-01-30 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| FR2833950B1 (en) | 2001-12-21 | 2005-12-16 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| FR2833955B1 (en) * | 2001-12-21 | 2004-01-30 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| FR2854634B1 (en) * | 2003-05-05 | 2005-07-08 | Servier Lab | NOVEL THIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| FR2856065B1 (en) * | 2003-06-13 | 2005-08-19 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| FR2856064B1 (en) * | 2003-06-13 | 2005-08-19 | Servier Lab | NOVEL BENZOTHIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| AU2004255581A1 (en) | 2003-07-02 | 2005-01-20 | F. Hoffmann-La Roche Ag | Arylamine-substituted quinazolinone compounds |
| JP2007504136A (en) | 2003-08-28 | 2007-03-01 | ニトロメッド インコーポレーティッド | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
| US7244843B2 (en) | 2003-10-07 | 2007-07-17 | Bristol-Myers Squibb Company | Modulators of serotonin receptors |
| FR2865474B1 (en) * | 2004-01-26 | 2008-06-13 | Servier Lab | NOVEL FLUORINATED BENZOTHIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| FR2877338B1 (en) | 2004-11-03 | 2007-01-26 | Servier Lab | NOVEL BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| FR2877342B1 (en) * | 2004-11-03 | 2007-01-26 | Servier Lab | NOVEL BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| FR2879201B1 (en) * | 2004-12-10 | 2007-02-16 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| US7238702B2 (en) | 2005-02-10 | 2007-07-03 | Bristol-Myers Squibb Company | Dihydroquinazolinones as 5HT modulators |
| CA2597460A1 (en) | 2005-02-24 | 2006-08-31 | Nitromed, Inc. | Nitric oxide enhancing diuretic compounds, compositions and methods of use |
| GB0507298D0 (en) * | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| TW200800959A (en) | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
| SG163545A1 (en) | 2007-01-03 | 2010-08-30 | Servier Lab | 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses |
| CL2008000119A1 (en) | 2007-01-16 | 2008-05-16 | Wyeth Corp | COMPOUNDS DERIVED FROM PIRAZOL, ANTAGONISTS OF THE NICOTINIC ACETILCOLINE RECEIVER; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS SENILE DEMENTIA, ALZHEIMER AND SCHIZOPHRENIA. |
| US8013003B2 (en) | 2007-05-17 | 2011-09-06 | Cortex Pharmaceuticals, Inc. | Di-substituted amides for enhancing glutamatergic synaptic responses |
| US8119632B2 (en) | 2007-08-10 | 2012-02-21 | Cortex Pharmaceuticals, Inc. | Bicyclic amide derivatives for enhancing glutamatergic synaptic responses |
| SG163526A1 (en) | 2007-08-10 | 2010-08-30 | Cortex Pharma Inc | Bicyclic amides for enhancing glutamatergic synaptic responses |
| FR2933698A1 (en) | 2008-07-09 | 2010-01-15 | Servier Lab | NOVEL CYCLOALKYLATED BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| FR2943342B1 (en) | 2009-03-20 | 2011-03-04 | Servier Lab | NOVEL BENZOTHIADIAZEPINES DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| AU2010276537B2 (en) | 2009-07-27 | 2015-04-16 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| FR2955106B1 (en) | 2010-01-08 | 2011-12-23 | Servier Lab | NOVEL CYCLOPROPYLATED BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| FR2955107B1 (en) * | 2010-01-08 | 2012-03-02 | Servier Lab | NOVEL THIOCHROMAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| EP2588197B1 (en) | 2010-07-02 | 2014-11-05 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| CN102958919A (en) * | 2010-07-02 | 2013-03-06 | 霍夫曼-拉罗奇有限公司 | Novel tetrahydroquinoline derivatives |
| FR2964969B1 (en) * | 2010-09-16 | 2012-08-24 | Servier Lab | NOVEL DIHYDROBENZOXATHIAZEPINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| IT1402905B1 (en) * | 2010-11-29 | 2013-09-27 | Univ Degli Studi Modena E Reggio Emilia | DERIVATIVES OF 1,2,4-BENZOTIADIAZIN 1,1-DIOXIDE, THEIR PREPARATION AND THEIR USE AS ALLOSTERIC MODULATORS OF THE AMPA RECEPTOR. |
| TWI510480B (en) | 2011-05-10 | 2015-12-01 | Gilead Sciences Inc | Fused heterocyclic compounds as ion channel modulators |
| TW201837023A (en) | 2011-07-01 | 2018-10-16 | 美商基利科學股份有限公司 | Fused heterocyclic compounds as ion channel modulators |
| NO3175985T3 (en) | 2011-07-01 | 2018-04-28 | ||
| CN102977054A (en) * | 2012-12-12 | 2013-03-20 | 中国药科大学 | Application of selective alpha2A receptor stimulant in treating alzheimer disease |
| MA38679B1 (en) | 2013-05-30 | 2019-12-31 | Idorsia Pharmaceuticals Ltd | Cxcr7 receiver modulators |
| JO3316B1 (en) | 2013-05-30 | 2019-03-13 | Lilly Co Eli | 3,4-dihydroisoquinolin-2(1h)-yl compounds |
| CN103275016B (en) * | 2013-06-04 | 2015-03-11 | 温州医科大学附属第二医院 | Synthetic method of 2-subsituted quinazoline compounds |
| WO2014201411A1 (en) | 2013-06-13 | 2014-12-18 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
| CN103319381B (en) * | 2013-06-14 | 2014-08-27 | 湖州康企药业有限公司 | Preparation method of high-purity fine sulfanilamide |
| CN103772296B (en) * | 2013-12-19 | 2015-06-17 | 安徽师范大学 | Synthesis method for quinazoline derivative |
| WO2016087370A1 (en) | 2014-12-01 | 2016-06-09 | Actelion Pharmaceuticals Ltd | Cxcr7 receptor modulators |
| CN105294599B (en) * | 2015-09-17 | 2017-09-22 | 三峡大学 | A kind of diazthines compound and its asymmetric synthetic method |
| CN106946920A (en) * | 2017-04-05 | 2017-07-14 | 泰力特医药（湖北）有限公司 | A kind of preparation method of 4 amino phenyl boronic acid derivative |
| WO2020253860A1 (en) * | 2019-06-21 | 2020-12-24 | 江苏豪森药业集团有限公司 | Aryl phosphorus oxide derivative inhibitor, preparation method therefor and use thereof |
| RU2726456C1 (en) * | 2019-10-02 | 2020-07-14 | Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") | Hepatitis b virus (hbv) inhibitor |
| CN111100042B (en) * | 2019-11-18 | 2022-05-31 | 苏州诚和医药化学有限公司 | Preparation method of 2-methoxy-5-sulfonamide benzoic acid |
| CN111018750B (en) * | 2019-12-19 | 2022-05-27 | 苏州诚和医药化学有限公司 | Novel preparation method of 2, 3-dimethoxy-5-sulfamide benzoic acid |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL296964A (en) * | ||||
| US3275625A (en) * | 1966-09-27 | Derivatives of | ||
| FR1217929A (en) * | 1958-03-03 | 1960-05-06 | Ciba Geigy | Process for the preparation of 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide and its salts |
| GB863474A (en) * | 1958-08-13 | 1961-03-22 | Knud Abildgaard | Benzothiadiazine derivatives and their preparation |
| DE1125938B (en) * | 1960-02-12 | 1962-03-22 | Thomae Gmbh Dr K | Process for the preparation of 7-sulfamyl-3, 4-dihydro-1, 2, 4-benzothiadiazine-1, 1-dioxydes |
| GB946864A (en) * | 1960-05-06 | 1964-01-15 | Knud Abildgaard | Method for the production of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxides |
| US3419552A (en) * | 1961-04-12 | 1968-12-31 | Lilly Co Eli | Preparation of substituted dihydrobenzothiadiazine-1,1-dioxides |
| CH475269A (en) * | 1962-04-19 | 1969-07-15 | Hans Voigt Chem Pharm Fabrik D | Process for the preparation of 7-sulfonamido-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes |
| US3351595A (en) * | 1962-12-07 | 1967-11-07 | Ciba Geigy Corp | Derivatives of 3, 4-dihydro-2h-1, 2, 4-benzothiadiazine-1, 1-dioxide |
| US3311620A (en) * | 1963-05-31 | 1967-03-28 | Stanley C Bell | Fused ring benzothiadiazines |
| US3277086A (en) * | 1964-07-07 | 1966-10-04 | American Home Prod | 1, 2, 4-benzothiadiazine 1, 1-dioxides having a heterocyclic ring fused to the "b" face thereof |
| US4184039A (en) * | 1977-12-01 | 1980-01-15 | Paul Finkelstein | Benzothiadiazine 1, 1-dioxides |
| AU3957093A (en) * | 1992-04-15 | 1993-11-18 | Rhone-Poulenc Rorer S.A. | 3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxyl ic acid derivatives, preparation thereof and drugs containing same |
| US5488049A (en) * | 1993-12-10 | 1996-01-30 | Fidia - Georgetown Institute For The Neuro-Sciences | Method of treating learning and memory disorders using benzothiadiazide derivatives as nootropic agents |
| FR2722502B1 (en) * | 1994-07-12 | 1996-08-23 | Adir | NOVEL BENZOTHIADIAZINE DERIVATIVE, ITS PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| JP2000507212A (en) * | 1996-01-29 | 2000-06-13 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | How to treat sexual dysfunction |
| WO1998012185A1 (en) * | 1996-09-17 | 1998-03-26 | The Regents Of The University Of California | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
-
1999
- 1999-02-18 HU HU0101280A patent/HUP0101280A3/en unknown
- 1999-02-18 NZ NZ506251A patent/NZ506251A/en unknown
- 1999-02-18 JP JP2000532408A patent/JP2002504481A/en not_active Withdrawn
- 1999-02-18 EP EP99904730A patent/EP1071426A2/en not_active Withdrawn
- 1999-02-18 EE EEP200000468A patent/EE200000468A/en unknown
- 1999-02-18 TR TR2000/02427T patent/TR200002427T2/en unknown
- 1999-02-18 SK SK1189-2000A patent/SK11892000A3/en unknown
- 1999-02-18 AU AU25123/99A patent/AU751384B2/en not_active Ceased
- 1999-02-18 CA CA002320354A patent/CA2320354A1/en not_active Abandoned
- 1999-02-18 CN CN99804196A patent/CN1293665A/en active Pending
- 1999-02-18 IL IL13772099A patent/IL137720A0/en unknown
- 1999-02-18 WO PCT/DK1999/000070 patent/WO1999042456A2/en not_active Application Discontinuation
- 1999-02-18 PL PL99342843A patent/PL342843A1/en unknown
- 1999-02-18 RU RU2000121882/04A patent/RU2214405C2/en not_active IP Right Cessation
- 1999-02-18 ZA ZA9901301A patent/ZA991301B/en unknown
-
2000
- 2000-08-04 IS IS5581A patent/IS5581A/en unknown
- 2000-08-17 NO NO20004121A patent/NO20004121L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS5581A (en) | 2000-08-04 |
| NZ506251A (en) | 2003-01-31 |
| EP1071426A2 (en) | 2001-01-31 |
| JP2002504481A (en) | 2002-02-12 |
| SK11892000A3 (en) | 2001-02-12 |
| PL342843A1 (en) | 2001-07-16 |
| RU2214405C2 (en) | 2003-10-20 |
| WO1999042456A2 (en) | 1999-08-26 |
| EE200000468A (en) | 2002-04-15 |
| NO20004121D0 (en) | 2000-08-17 |
| AU751384B2 (en) | 2002-08-15 |
| HUP0101280A2 (en) | 2001-10-28 |
| CA2320354A1 (en) | 1999-08-26 |
| HUP0101280A3 (en) | 2003-02-28 |
| CN1293665A (en) | 2001-05-02 |
| AU2512399A (en) | 1999-09-06 |
| IL137720A0 (en) | 2001-10-31 |
| NO20004121L (en) | 2000-10-17 |
| WO1999042456A3 (en) | 1999-10-07 |
| TR200002427T2 (en) | 2001-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA991301B (en) | Glutamate receptor modulators. | |
| HK1035671A1 (en) | Adenosine a3 receptor modulators. | |
| ZA200108846B (en) | Glucocorticoid receptor modulators. | |
| GC0000117A (en) | Ccr5 modulators. | |
| ZA98970B (en) | N-hydroxy-ß-sulfonyl propionamide derivatives. | |
| HK1017317A1 (en) | Printer. | |
| ZA988078B (en) | Substituted oxindole derivatives. | |
| HK1016976A1 (en) | Resorcinyl-triazine. | |
| ZA9811473B (en) | Arylpiperazines having activity at the serotonin 1A receptor. | |
| ZA981017B (en) | 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines. | |
| ZA981926B (en) | Detergent--package combination. | |
| ZA987055B (en) | Substituted 4-benzoylpyrazoles. | |
| DE59804842D1 (en) | Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen | |
| ZA987058B (en) | Substituted 4-benzoylpyrazoles. | |
| ZA982436B (en) | Thiazolimine derivatives. | |
| EP1084142A4 (en) | Gpr35a receptor | |
| HK1017834A1 (en) | Bodyshaper. | |
| ZA983705B (en) | Pregnan-3-ol-20-ones. | |
| HK1016333A1 (en) | Kara-ok device. | |
| ZA987B (en) | Substituted 4-benzoylpyrazoles. | |
| ZA981338B (en) | Neurturin receptor. | |
| GB9819420D0 (en) | Novel receptor | |
| EP1083909A4 (en) | hCEPR RECEPTOR | |
| ZA981309B (en) | 4-aminoalkoxy-1H-benzoimidazoles. | |
| HK1017240A1 (en) | Clip. |